Crossmark

Association of metabolic risk factors with the severity of hepatic fibrosis and steatosis in metabolic dysfunction-associated fatty liver disease patients

Crossref DOI link: https://doi.org/10.1186/s43066-025-00468-2

Published Online: 2025-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elsabaawy, Maha https://orcid.org/0000-0002-3110-1547
Othman, Warda

Afify, Sameh

Samir, Tamer

Naguib, Madiha
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 6 November 2024

Accepted: 9 October 2025

First Online: 16 October 2025

Declarations

:

: This study was performed according to the principles of the Declaration of Helsinki. This study was approved by the Ethics Committee of the National Liver Institute, Menoufia University, as unique research and not part of an approved student thesis.Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below